Denise Guetard

This inventor holds 33 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in HIV Diagnostics. Top assignees: Institut Pasteur, Other. Active years: 1989-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denise Guetard. Retrieved from https://idiyas.com/inventor/denise-guetard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 84.8

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 273(Granted Patents)

Location History:

75015 Paris, FR (2001)
Paris, FR (1989 - 2012)

Company Filing History:

32 out of 898

Institut Pasteur

patents

1 out of 834,513

Other

patents

Years Active: 1989-2012

Loading Chart...

Areas of Expertise:

HIV-1

HIV-2

Nucleotide Sequences

Antigen Compositions

Diagnostic Assays

Peptides

In Vitro Detection

Immunological Methods

Nucleic Acids

Antibodies

Kits

Retrovirus

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8236324 - Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens (2012-08-07),

2. 7341731 - HIV-2 antigen compositions (2008-03-11),

3. 7157225 - Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens (2007-01-02),

4. 7115363 - Retrovirus capable of causing AIDS, means and methods for detecting it in vitro (2006-10-03),

5. 6979535 - Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays (2005-12-27),

6. 6664041 - Method for preparing a viral extract containing HIV-II RNA (2003-12-16),

7. 6514691 - Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2 (2003-02-04),

8. 6429306 - Nucleic acids of a human immunodeficiency virus type 2 (HIV-2) (2002-08-06),

9. 6399294 - Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens (2002-06-04),

10. 6316183 - Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2) (2001-11-13),

11. 6296807 - Kits for the detection of human immunodeficiency virus type 2 (HIV-2) antigens (2001-10-02),

12. 6265149 - In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies (2001-07-24),

13. 6162439 - Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of (2000-12-18),

14. 616243 - Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of (2000-12-19),

15. 6037165 - Methods for the preparation of human immunodeficiency virus type 2 (2000-03-14),

Title: Denise Guetard: A Pioneer in HIV Research

Introduction

Denise Guetard is a renowned inventor based in Paris, France, known for her significant contributions to the understanding and treatment of HIV. With an impressive portfolio of 33 patents, Guetard has pioneered advancements in retroviral research, specifically focusing on HIV-1 and HIV-2 viruses.

Latest Patents

Among her latest patents, Denise Guetard has developed innovations related to nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens. This includes unique proteins or synthetic peptides that can be recognized by antibodies from individuals infected with specific HIV-1 strains. Additionally, she has contributed to the field of HIV-2 with a patent concerning compositions that include antigens capable of initiating an immune response against the HIV-2 virus. This invention also outlines a process for producing these retrovirus antigens through cellular lysis.

Career Highlights

Denise Guetard has built her career at leading research institutions, including the prestigious Institut Pasteur. Her extensive work in virology has deeply impacted HIV-related research, leading to better understanding and potential therapeutic strategies for the virus.

Collaborations

Throughout her career, Guetard has collaborated with prominent scientists in the field, such as Luc Montagnier and Francois Clavel. These partnerships have further enriched her research and contributed to groundbreaking discoveries in retroviral diseases.

Conclusion

Denise Guetard's work continues to inspire and drive innovation in the world of HIV research. Her patents demonstrate her commitment to advancing medical knowledge and developing new strategies to combat retroviral infections. Through her contributions, she solidifies her status as a significant figure in virology and infectious disease research.

Profile summary based on public USPTO records.